Business ❯ Corporate Law ❯ Litigation

Securities Fraud

Investor Relations Legal Representation Investor Protection Investor Compensation Misleading Statements Material Misrepresentation False Statements Shareholder Rights Investor Claims

UniQure Investors Face Lead‑Plaintiff Deadline in Securities Fraud Case

The dispute over FDA acceptance of external controls could shape uniQure’s approval timeline.

Law Firms Press Corcept Investors to Seek Lead Role in Securities Case Before April 21

ImmunityBio Faces Growing Securities Suits After FDA Flags Misleading Anktiva Claims

Apple Moves to Toss Shareholder Fraud Suit Over Siri AI and App Store Ruling

Skye Bioscience Investors Face Jan. 16 Deadline in Securities Class Action Over Nimacimab Disclosures

Investor Firms Step Up Bid to Lead CarMax Securities Case as Jan. 2 Deadline Looms